This is a past event. Registration is closed. View more events from DIA China

OVERVIEW

On May 21-24, 2017, the DIA China Annual Meeting will bring together global pharmaceutical professionals to discuss critical topics and themes surrounding the regulation, discovery, development, and life cycle management of health care products. The theme of this meeting, “Drug Innovation Driven by Unmet Medical Needs,” will attract more than 2000 pharmaceutical R&D professionals from different continents and regions, involved at all levels of the health care product development spectrum. Please join us to discuss recent and upcoming transformational changes for China’s innovation and regulatory environments.

This year will also debut our special DIAmond Sessions, which will introduce global views into our perspective of the Chinese pharmaceutical eco-environment. Sessions will model the experience from the global DIA 2016 Annual Meeting in the US. As the largest multidisciplinary event in DIA Asia, other highlights will include 100+ exhibit booths and a new, unique hub for R&D and emerging companies to showcase themselves in “Innovation Hub.”

Come and join our neutral, global platform to exchange knowledge, advance change, and cross collaborate towards patient-centric biopharmaceutical innovation.
 
  • May 21, 2017: Pre-Conference Workshop
  • May 22-24 2017: Conference, Exhibition and Poster Show

CO-CHAIRS

Ning XU, MD, MBA
Executive Vice President, Head of Clinical Development and Regulatory Affairs, Zai Lab
 
Bin XUE
Director-General, China Center for Food and Drug International Exchange, China Food and Drug Administration

STEERING COMMITTEE

Bei HU, PhD, Prof.
Director, Clinical Pharmacological Research Center, Peking Union Medical College Hospital
 
Janet LV
Head of Regulatory, Asia Pacific, Roche (China) Ltd.
 
Ying SHAO, PhD
Vice President and Director of R&D Center, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
 
Ling SU, PhD
Professor and Director, Institute of Drug Regulatory Science, Shenyang Pharmaceutical University
Venture Partner, Lilly Asia Ventures
JingSong WANG, MD, PhD
Advisor to Atlas Venture
 
Ning XU, MD, MBA
Executive Vice President, Head of Clinical Development and Regulatory Affairs, Zai Lab
Co-Chairs, 9th DIA China Annual Meeting
 
Bin XUE
Director-General, China Center for Food and Drug International Exchange, China Food and Drug Administration
Co-Chairs, 9th DIA China Annual Meeting
 
Carol ZHU, MBA
Senior Vice President and Managing Director, DIA Greater China

Innovation Harbor

Innovation is where the charm of the era lies in, and innovation is the soul of an enterprise’s progress. There is no exception for the pharmaceuticals industry. 

The 2017 DIA China Annual Meeting has for the first time arranged the “Innovation Harbor” exhibition area, with a view to integrating innovation factors of the pharmaceuticals industry, finding companies with the R&D capacity and potential, better discovering talents, screening projects, attracting capitals, and supporting innovation and business start-up in the industry, providing talents dreaming for innovations in the industry with opportunities for realizing sound growth in their innovation programs, and promoting China’s medicine R&D.  

媒体合作伙伴

Location


China

See route

Contact us

For additional event or venue information, please email fei.xie@diaglobal.orgYou can also reach us at +86 01057042659